Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD27 antigen is a type I transmembrane glycoprotein and a member of the tumor necrosis factor receptor superfamily (TNFRSF7). It functions as a costimulatory immune-checkpoint receptor, primarily expressed on T cells, natural killer (NK) cells, and B cells. CD27 plays an essential role in regulating immune responses, particularly in T cell activation, survival, and memory formation. Its ligand is CD70. CD27 is under investigation as an immunotherapy target and soluble forms may serve as biomarkers.
CD27 co-stimulation; Checkpoint regulation modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD27 antigen (CD27).